Skip to content
Natural catalysts for energy conversion processes

Protection for Biocatalysts: Ruhr University Bochum & ISAS Bring Iodide Salts into Play

Dortmund, 14th February 2020

Iodide salts as the key to sustainable success of biocatalysts in fuel cells? The mass use of fuel cells could make large power plants and high-voltage lines superfluous, make cars run emission-free and turn homeowners into their own electricity producers. But: One type of catalysts - precious metals like platinum - are very expensive and the resources are decreasing more and more. The second type of catalyst would be highly abundant: biological and bio-inspired catalysts. Nevertheless, these natural catalysts have so far hardly been used for energy conversion processes. This is because these catalysts are often so sensitive to oxygen that they stop functioning within a few seconds.

How to solve this?  A research team led by Prof. Dr. Nicolas Plumeré from the Ruhr University Bochum (RUB), Dr. Erik Freier and Dr. Ute Münchberg from the Leibniz-Institut für Analytische Wissenschaften in Dortmund (ISAS) and Prof. Dr. Wolfgang Lubitz from the Max Planck Institute for Chemical Energy Conversion in Mülheim dealt with this issue. They report in the renowned journal Nature Communications on 14 February 2020: "Iodide salts make biocatalysts for fuel cells stable".

Infinite protection - so far only in theory

The research group recently discovered that redox-active films can protect bio-inspired and even biocatalysts such as hydrogenases from oxygen. Theoretical models predict that protection against oxygen should last indefinitely. In experiments, however, this protection is only effective for a few hours. "This contradicts our theoretical calculations and cannot be explained, especially considering the lifetime of the same catalyst in an oxygen-free environment," says Plumeré. The latter is up to six weeks with constant turnover.

Combination of methods gets to the bottom of the problem

The researchers concluded that either the mechanism for protection against oxygen is not yet understood, or that in addition to deactivation by oxygen, additional harmful processes take place. To investigate this, they combined various methods that allowed them to examine exactly what happens in the protective layer. The combination of confocal fluorescence microscopy and coherent anti-Stokes Raman scattering performed in the laboratory of Erik Freier at ISAS with electrochemistry for the analysis of the protective matrix showed: The protective process leads to an accumulation of hydrogen peroxide damaging the catalytic film.

Suppress hydrogen peroxide formation

The work shows that the splitting of hydrogen peroxide using iodide salts increases the half-life of a hydrogenase for hydrogen oxidation to up to one week at constant turnover, even when exposed to constant high oxygen concentrations. "Overall, our data confirm the theory that redox films make oxygen-sensitive catalysts completely immune to direct deactivation by oxygen," summarizes Plumeré. "However, it is very important to also suppress hydrogen peroxide production in order to achieve complete protection against oxidative stress."

"Our work shows that the simple strategy of adding iodide salts to the electrolyte can be sufficient to significantly reduce the inactivation rates of biocatalysts," said the researchers. In their opinion, this will enable the widespread implementation of other electrocatalytic processes in real applications. This also includes energy conversion processes such as solar fuel generation through carbon dioxide reduction and the electrosynthesis of fine or basic chemicals such as ammonia.

Funding

The work was funded by the German Research Foundation as part of the Ruhr Explores Solvation Resolv Cluster of Excellence (EXC-2033 - project number 390677874) and the Shields project (PL 746/2-1) and by the European Research Council as part of Starting Grant 715900. Further support came from the Max Planck Society, the China Scholarship Council and the Ministry of Culture and Science of North Rhine-Westphalia, the Governing Mayor of Berlin - including Science and Research, and the Federal Ministry of Education and Research and the Leibniz Research Cluster (031A360E).

Original publication

Huaiguang Li, Ute Münchberg, Alaa A. Oughli, Darren Buesen, Wolfgang Lubitz, Erik Freier, Nicolas Plumeré: Suppressing hydrogen peroxide generation to achieve oxygen-insensitivity of a [NiFe] hydrogenase in redox active films, in: Nature Communications 2020, DOI: 10.1038/s41467-020-14673-7

Further Links

Read here the article on the topic, which was published in Nature Communications on 14.02.2020.

Click here for the RUB press release.

Share

Further press releases

13th July 2026

Fabry Disease: a Molecular Map of Lipids in Tissue

A new technique developed at ISAS combines Raman microscopy and mass spectrometry imaging, and it demonstrates that, for the first time, the spatial distribution of lipids can be visualised at cellular and subcellular levels – including further essential information. The new analytical method holds high potential for the diagnosis and treatment of conditions such as Fabry disease, in which molecules undergo local changes within the tissue.

2nd July 2026

Biomedical Image Analysis with AI

Dr Jianxu Chen is taking up a professorship in AI for Biomedical Analysis at the University of Duisburg-Essen. With his research group at ISAS, he is developing AI methods that can be used to comprehensively analyse enormous quantities of complex microscopy images.

Portrait von Dr. Jianxu Chen.
29th June 2026

It's What's Inside That Counts: Neutrophils Form Distinct Subtypes

Neutrophils can be divided into two distinct subgroups with completely different functions. The surface protein CD177 plays a decisive role in this. For the first time, researchers from the Faculty of Medicine at the University of Duisburg-Essen and ISAS have been able to demonstrate, using a new integrated proteomics and lipidomics analysis, that the molecular signatures in CD177-defined neutrophils differ significantly from one another. The presence of this surface protein has implications for disease progression, for example in head and neck tumours.

CD177 negative Neutrophile.
26th November 2025

New Drug Candidates for the Treatment of Heart Failure

Researchers from North Rhine-Westphalia are working on a new therapeutic approach for the treatment of heart failure as part of the recently launched HI-FIVE project. They are developing active substances that specifically inhibit an important enzyme with the aim of closing gaps in the care of patients with heart failure.

26th September 2025

Microbiome Research: EU Network METAMIC 3 Is Looking for Doctoral Candidates

In the new EU network METAMIC 3, young scientists will be researching the role of microbiomes in the context of ‘One Health’ for their dissertations. Metaproteomics methods will be applied in this research. Furthermore, stays at various European institutions are part of the doctoral programme. The doctoral positions are now open for applications.

Prof. Dr. Robert Heyer is Head of the research group Multidimensional Omics Data Analysis at ISAS and coordinator of the network.
7th February 2025

The Less the Better

If neutrophil granulocytes migrate into injured tissue, for example into the brain after a stroke, they can promote chronic inflammation and cause long-term damage. In order to analyze the functional dynamics of these immune cells, millions of them are needed. A group of researchers recently developed a method that enables mass spectrometric analysis with just 1,000 neutrophils.

Susmita Ghosh am Massenspektrometer.